This week, the small and medium-sized board refers to a strong move. On the one hand, it benefits from the big environment of the A-share market, not only the opening of the window of stability, but also the positive and optimistic changes in the environment of the A-share market including small and medium-sized boards. . For example, the intensive introduction of real estate industry policies means that there is a positive change in the direction of social wealth distribution. The equity market with good liquidity and long-term development direction has become a new allocation target of social wealth. Therefore, the holdings of stock funds have increased. Incremental funds also began to increase slightly. In a market with good chip lock performance, a slight buy will drive the index to pick up.
On the other hand, it benefits from the emergence of new industrial policy theme catalysts from time to time. For example, in the early stage, the double-point system for new energy-powered vehicles and the timetable for fuel vehicles to exit the market have stimulated the stock prices of related brands in lithium batteries and other related industries to continue to be strong. In the near future, there are new theme catalysts in the industrial fields such as medicine and artificial intelligence.
In particular, the pharmaceutical industry has more frequent industrial policies in the near future. On October 8, the State Council issued the "Opinions on Deepening the Reform of the Examination and Approval System to Encourage the Innovation of Pharmaceutical Medical Devices", and proposed 36 articles from six aspects: reforming clinical trial management, speeding up the approval of listing review, promoting drug innovation and the development of generic drugs. Specific measures to encourage enterprises to develop new drugs and innovative medical devices have an important role in the future development of the medical industry . On October 9, the State Council executive meeting deployed a comprehensive reform plan to fully open public hospitals to further solve the worldwide problem of medical reform. This means that the pharmaceutical industry has entered the turmoil of policy warm winds, and the strength of the small and medium-sized board is expected to continue.
In operation, investors are advised to track strong stocks. Among them, the pharmaceutical stocks are expected to become the new engine of the small and medium board. Participants are advised to use the intraday volatility to actively absorb low-yielding pharmaceutical stocks. First, the relevant stocks that are in line with the current medical reform, mainly the grading diagnosis benefit category, the consistency evaluation benefit stocks. Second, industrial stocks with relatively unique drugs, such as anesthetics, competition for controlled drugs are relatively moderate, and stocks such as Enhua Pharmaceutical can be tracked. For example, blood products stocks, after the stock price adjustment of the first half of the year, the license advantage is expected to show up, and the stocks of Hualan Biological and other stocks in the industry's leading varieties can be tracked.
Insulin Syringes Needle,Disable Syringe,Monoject Syringe,10 Ml Syringe
FOSHAN PHARMA CO., LTD. , https://www.full-pharma.com